If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
259.00    -8.00 (-3.00%)
Bid:
255.00
Ask:
263.00
Spread: 8.00 (3.137%)
Market Cap: £235.28m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

13 May 2013 16:25

RNS Number : 5957E
Concurrent Technologies PLC
13 May 2013
 



13 May 2013

Concurrent Technologies Plc

 

Rich I/O feature set enhances high performance 6U VME processor board

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce a further addition to its family of high performance VME processor boards. Utilizing the power-efficient 3rd generation Intel® Core™ processor, the VP 92x/x1x offers a very wide choice of front and rear I/O interfaces and by using XMC or PMC modules this I/O feature set can be further extended. Optional configurable proprietary integrated security features make the board highly suitable for a wide range of new and existing applications within the defence, energy, scientific and industrial markets.

 

The VP 92x/x1x is available in commercial and extended temperature variants with a choice of dual or quad core processors. For ease of integration, the VP 92x/x1x supports many of today's leading operating systems, including Linux®, Windows® and VxWorks®.

 

This launch is in line with the Company's product development strategy of designing more innovative products for complex, high technology, low to medium volume and high margin applications. These products not only provide a technology pathway for the Company's existing customers in defence and telecommunications where high-reliability and fast, high volume processing is required, but also in additional markets such as energy, scientific and industrial.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"The I/O interfaces on the VP 92x/x1x Single Board Computer have been tailored specifically to meet the requirements of our customers' applications where, in particular, additional front panel graphics and Ethernet interfaces are required. This board will particularly appeal to today's VME users looking to extend the life cycle of their existing systems and applications through enhanced processing and graphics performance."

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, Managing Director

 

+44 (0)1206 752 626

Newgate Threadneedle (Financial PR)Caroline Evans-Jones

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Ken FlemingNeil McDonald

+44 (0)131 220 6939+44 (0)131 220 9771

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 3rd generation Intel® Core™ i7, 2nd generation Intel® Core™ i7, Intel® Core™ i7 processors, Intel® Xeon® and Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLAJMATMBTBBMJ
Date   Source Headline
13th Nov 202011:58 amRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update
14th Jan 20192:00 pmRNSLeave of Absence
8th Oct 20187:00 amRNSProduct Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.